Catalyst Wire Dossier Catalyst Wire Dossier

Desloratadine 2.5 mg Reditab (SCH34117)

desloratadine · Organon and Co
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Desloratadine 2.5 mg Reditab (SCH34117), covering 2010-07-05 to 2010-07-05. Get the full timeline:

Most recent: Clinical Trial Update: Multi-center, Pediatric, Open-label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec 5.0 mg Chewable Tablet Medications (Study P04574)(COMPLETED) [Phase 4]

See pricing